Literature DB >> 1161992

Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.

P F Anderson, D M Jackson, G B Chesher, R Malor.   

Abstract

The onset and duration of tolerance to three effects of delta9-tetrahydrocannabinol (delta9-THC) given orally to mice were compared. The effects of delta9-THC studied were: hypothermia, the depression of intestinal motility and the effect on spontaneous locomotor activity. When mice were dosed and tested at 24 hrs intervals it was apparent that tolerance was complete to its hypothermic and locomotor depressant effects after the first doses and to depression of intestinal motility after the fourth dose. Duration of tolerance also differed so that the normal hypothermic response had returned after 12 dose-free days, but not after 5 drug-free days; the effect on locomotor activity had returned within 4 days; and apparent partial tolerance to the depressant effect of an acute challenging dose of delta9-THC on intestinal motility still existed after 19 dose-free days. It is apparent that the time of onset and the duration of tolerance to delta9-THC in mice showed a different pattern in the three parameters studied. It seems unlikely therefore that any one mechanism, such as metabolic tolerance, explains all the results observed and that several mechanisms should be explored to explain the phenomenon of tolerance to delta9-THC.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1161992     DOI: 10.1007/bf00437611

Source DB:  PubMed          Journal:  Psychopharmacologia


  19 in total

1.  Interaction between delta 9-tetrahydrocannabinol and morphine on the motor activity of mice.

Authors:  I H Ayhan; S Kaymakçalan; F C Tulunay
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

2.  Chronic delta9-tetrahydrocannabinol in rats: effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature.

Authors:  K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

Review 3.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.

Authors:  Fabio Guagnini; Paola Cogliati; Sylvain Mukenge; Gianfranco Ferla; Tiziano Croci
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

5.  Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Authors:  Emmanuel Valjent; Jennifer M Mitchell; Marie-Jo Besson; Jocelyne Caboche; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats.

Authors:  Jacques D Nguyen; Yanabel Grant; Tony M Kerr; Arnold Gutierrez; Maury Cole; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2018-07-19       Impact factor: 3.533

7.  Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.

Authors:  Bogna Ignatowska-Jankowska; Jenny L Wilkerson; Mohammed Mustafa; Rehab Abdullah; Micah Niphakis; Jenny L Wiley; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2015-03-11       Impact factor: 4.030

8.  Stimulant actions of delta9-tetrahydrocannabinol in mice.

Authors:  M A Evans; R D Harbison; D J Brown; R B Forney
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

9.  Molecules Acting on CB1 Receptor and their Effects on Morphine Withdrawal In Vitro.

Authors:  Anna Capasso; Chiara Gallo
Journal:  Open Biochem J       Date:  2009-12-11

10.  The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.

Authors:  F C Tulunay; I H Ayhan; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.